Fortrea vs Sotera Health
FTRE and SHC side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FTRE and SHC compare
Sotera Health is the larger company, worth 2.4 times as much as Fortrea ($4.7B against $1.9B).
Sotera Health grew revenue faster over the last twelve months (8.1% versus −3.4% for Fortrea).
Sotera Health keeps more of each dollar of sales as profit, with a net margin of 13.4% compared with −2.6% at Fortrea.
Sotera Health scores higher on the StockData Score (7 against 4 for Fortrea), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FTRE | SHC |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $4.7B |
| Share price | $20.20 | $16.61 |
| Change, 1 year | 78.1% | 2.2% |
| Change, 5 years | – | −26.3% |
| Beta (5Y) | 1.46 | 1.59 |
| Employees | 14K | 3,000 |
| StockData Score | ||
| Total score | 4 | 7 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 2 | 3 (better) |
| Health score | 0 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 29.1× |
| P/S | 0.7× (better) | 3.9× |
| P/B | 3.7× (better) | 7.1× |
| EV/EBITDA | 30.4× | – |
| P/FCF | 11.5× (better) | 42.1× |
| FCF yield | 8.7% (better) | 2.4% |
| Fair value | $12.43 | – |
| Margin of safety | −62.5% | – |
| Growth | ||
| Revenue growth (TTM) | −3.4% | 8.1% (better) |
| Revenue growth, 5Y average | – | 7.3% |
| Net income growth (TTM) | – | 581% |
| EPS growth (TTM) | – | 613% |
| Profitability | ||
| Gross margin | 20.0% | 55.0% (better) |
| Operating margin | 0.48% | – |
| Net margin | −2.6% | 13.4% (better) |
| FCF margin | 6.3% | 9.3% (better) |
| Return on equity | −12.3% | 27.8% (better) |
| Return on invested capital | 0.69% | – |
| Financial health | ||
| Debt / equity | 1.98 (better) | 3.21 |
| Net debt / EBITDA | 9.12 | – |
| Current ratio | 0.97 | 2.80 (better) |
| Altman Z-score | 0.78 | 1.40 (better) |
| Piotroski F-score | 3 | 7 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 104% | 103% |
| Held by insiders | 3.9% | – |
| Insider net buying, 12 months | −$4.7M (better) | −$1.8B |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 9.2% | – |
Go deeper
- FTRE stock overview
- FTRE income statement
- FTRE valuation and score
- SHC stock overview
- SHC income statement
- SHC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.